Fanconi syndrome associated with didanosine therapy

被引：35

作者：

Izzedine, H ^{[1
]}

Launay-Vacher, V ^{[1
]}

Deray, G ^{[1
]}

机构：

[1] Hop La Pitie Salpetriere, Dept Nephrol, Paris, France

来源：

AIDS | 2005年 / 19卷 / 08期

关键词：

D O I：

10.1097/01.aids.0000168985.05209.b8

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：844 / 845

页数：2

共 7 条

[1]

CROWTHER MA, 1993, AIDS, V7, P131, DOI 10.1097/00002030-199301000-00025

[2] Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir [J].

Cundy, KC .

CLINICAL PHARMACOKINETICS, 1999, 36 (02) :127-143

[3] Renal safety of tenofovir in HIV treatment-experienced patients [J].

Izzedine, H ;

Isnard-Bagnis, C ;

Hulot, JS ;

Vittecoq, D ;

Cheng, A ;

Jais, CK ;

Launay-Vacher, V ;

Deray, G .

AIDS, 2004, 18 (07) :1074-1076

[4] Renal safety of adefovir dipivoxil in patients with chronic hepatitis B: Two double-blind, randomized, placebo-controlled studies [J].

Izzedine, H ;

Hulot, JS ;

Launay-Vacher, V ;

Marcellini, P ;

Hadziyannis, SJ ;

Currie, G ;

Brosgart, CL ;

Westland, C ;

Arterbrun, S ;

Deray, G .

KIDNEY INTERNATIONAL, 2004, 66 (03) :1153-1158

[5] FULMINANT HEPATIC-FAILURE ASSOCIATED WITH 2',3'-DIDEOXYINOSINE (DDI) [J].

LAI, KK ;

GANG, DL ;

ZAWACKI, JK ;

COOLEY, TP .

ANNALS OF INTERNAL MEDICINE, 1991, 115 (04) :283-284

[6] Nephrogenic diabetes insipidus and renal tubular acidosis secondary to foscarnet therapy [J].

Navarro, JF ;

Quereda, C ;

Gallego, N ;

Antela, A ;

Mora, C ;

Ortuno, J .

AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 27 (03) :431-434

[7] Tenofovir-related Fanconi syndrome with nephrogenic diabetes insipidus in a patient with acquired immunodeficiency syndrome:: The role of lopinavir-ritonavir-didanosine [J].

Rollot, F ;

Nazal, EM ;

Chauvelot-Moachon, L ;

Kélaïdi, C ;

Daniel, N ;

Saba, M ;

Abad, S ;

Blanche, P .

CLINICAL INFECTIOUS DISEASES, 2003, 37 (12) :E174-E176

← 1 →